|
|
Giuseppe Remuzzi, Ariela Benigni, Andrea Remuzzi
J Clin Invest. 2006;
116(2):288
doi:10.1172/JCI27699
Abstract |
Full text
| PDF
| Supplemental material

T
he incidence of chronic kidney diseases is increasing worldwide, and these conditions are emerging as a major public health problem. While genetic factors contribute to susceptibility and progression of renal disease, proteinuria has been claimed as an independent predictor of outcome. Reduction of urinary protein levels by various medications and a low-protein diet limits renal function decline in individuals with nondiabetic and diabetic nephropathies to the point that remission of the disease and regression of renal lesions have been observed in experimental animals and even in humans. In animal models, regression of glomerular structural changes is associated with remodeling of the glomerular architecture. Instrumental to this discovery were 3D reconstruction studies of the glomerular capillary tuft, which allowed the quantification of sclerosis volume reduction and capillary regeneration upon treatment. Regeneration of capillary segments might result from the contribution of resident cells, but progenitor cells of renal or extrarenal origin may also have a role. This review describes recent advances in our understanding of the mechanisms and mediators underlying renal tissue repair ultimately responsible for regression of renal injury.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(127)
| Title and authors |
Publication |
Year |
New options and perspectives for proteinuria management after kidney transplantation
María José Soler, Marta Riera, Álex Gutierrez, Julio Pascual
|
Transplantation Reviews
|
2012 |
Diabetic nephropathy and associated risk factors for renal deterioration
Sandesh Mohan, Kiran Kalia, Jyoti Mannari
|
Int J Diabetes Dev Ctries
|
2012 |
Urinary Tract
Peter Greaves
|
Histopathology of Preclinical Toxicity Studies
|
2012 |
Effective blockade of RAAS by combination of Aliskiren and Olmesartan improves glucose homeostasis, glomerular filtration rate along with renal variables in streptozotocin induced diabetic rats
Sonia Gandhi, B.P. Srinivasan, Atul Sureshrao Akarte
|
European Journal of Pharmaceutical Sciences
|
2012 |
Endothelin and the podocyte
M. Barton, P.-L. Tharaux
|
Clinical Kidney Journal
|
2012 |
What is the best method of proteinuria measurement in clinical trials of endothelin receptor antagonists?
Jonathan D. Towler, Neeraj Dhaun, Margaret MacDougall, Vanessa Melville, Jane Goddard, David J. Webb
|
Life Sciences
|
2012 |
Proteinuria should be used as a surrogate in CKD
Paolo Cravedi, Piero Ruggenenti, Giuseppe Remuzzi
|
Nat Rev Nephrol
|
2012 |
Chronic kidney disease, severe arterial and arteriolar sclerosis and kidney neoplasia: on the spectrum of kidney involvement in MELAS syndrome
Giorgina Piccoli, Laura Bonino, Paola Campisi, Federica Vigotti, Martina Ferraresi, Federica Fassio, Isabelle Brocheriou, Francesco Porpiglia, Gabriella Restagno
|
BMC Nephrol
|
2012 |
Hepatocyte growth factor gene therapy enhances infiltration of macrophages and may induce kidney repair in db/db mice as a model of diabetes
M. Flaquer, M. Franquesa, A. Vidal, N. Bolaños, J. Torras, N. Lloberas, I. Herrero-Fresneda, J. M. Grinyó, J. M. Cruzado
|
Diabetologia
|
2012 |
Proteins and renal fibrosis: low-protein diets induce Kruppel-like factor-15, limiting renal fibrosis
Yanlin Wang, William E Mitch
|
Kidney Int
|
2011 |
|